Blood infection tracking study across Europe
Part of Infections clinical trials.
This study gathers information about blood infections to better understand them and improve care. It may help by providing detailed data on your specific infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive blood culture result (a test showing bacteria in your blood).
- Only the first positive blood culture in 90 days counts.
- Your hospital is part of this European study and has access to your lab results and medical records.
- You must be 18 years or older.
- For the management part, you need an infection with specific bacteria, like Staphylococcus aureus or E. coli.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
This trial tests a new rapid blood test (Cobas Eplex) that may help doctors identify the cause of a bloodstream infection faster than standard methods. If you are an adult or child hospitalized for a blood infection, this study could lead to quicker, more targeted treatment.
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
This study collects medical information and optional biological samples (like blood or saliva) from people with an active or suspected infection. The goal is to build a large database that can help researchers better understand infectious diseases and develop new ways to diagnose and treat them.
This study tests a careful antibiotic-use program for patients with a bloodstream infection caused by a group of bacteria called Enterobacterales. The goal is to use the right antibiotics for the right amount of time. It may help you get better treatment with fewer side effects.
This trial is testing a new method (IDBIORIV) to quickly identify the germs causing sepsis and find the right antibiotic. It aims to help patients with a confirmed bloodstream infection get the most effective treatment faster.
Hear when a new Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.